Promoter Docon releases pledge on 1.75 crore Thyrocare shares

Pledge releasedPromoter pledge above 50%Ownership Changes View source PDF Explain this filing

THYROCARE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-6.2%Reaction day

₹643.05

prior close

₹613.40

announcement price

In-mkt

timing

Nifty Microcap 250market+0.2%-6.4% vs market

Healthcare Service Provider peers, median of 26sector+0.4%-6.7% vs sector

On the reaction day the stock moved 6.4 pts less than Nifty Microcap 250 and 6.7 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

+0.3

15m

+0.4

30m

+0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-6.2+0.2-6.4+0.4-6.7

Next day

-2.8+0.2-3.1-2.1-0.8

-3.6+0.4-3.9-0.8-2.8

-5.1+0.7-5.9-0.9-4.2

-9.8+0.1-9.9-2.5-7.3

-11.8+0.7-12.5-1.0-10.8

-8.9+1.2-10.1-0.3-8.5

15d

-10.1+0.7-10.9-0.8-9.3

-14.8-1.2-13.6+0.0-14.8

-22.4-1.1-21.3-4.7-17.7

—————

UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 26Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Promoter Docon Technologies (holds 60.92% in Thyrocare) got pledge released on 1,75,00,000 shares (10.99% of capital) by Catalyst Trusteeship on Aug 11, 2026. Encumbered shares fall from 60.92% to 49.93%. Promoter stake unchanged. Pledge backed NCDs of API Holdings worth INR 10,500 million.

Likely market impact

Positive: reduced encumbrance on promoter shares improves financial flexibility. Promoter stake and voting rights unchanged.